Theranostic radiopharmaceutical therapies based on isotopes such as Ac-225 and At-211 are growing in clinical importance for cancer therapy. This burgeoning field has several facets that provide opportunities for improvement that will lead to better outcomes for patients or lead to fewer side effects. In this session, we will explore advances in the field that are leading to improved imaging methodologies and dosimetry.